These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
538 related articles for article (PubMed ID: 31330079)
21. Synthesis, in vitro and computational studies of 1,4-disubstituted 1,2,3-triazoles as potential α-glucosidase inhibitors. Jabeen F; Shehzadi SA; Fatmi MQ; Shaheen S; Iqbal L; Afza N; Panda SS; Ansari FL Bioorg Med Chem Lett; 2016 Feb; 26(3):1029-1038. PubMed ID: 26725952 [TBL] [Abstract][Full Text] [Related]
22. Synthesis, in vitro α-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs. Javid MT; Rahim F; Taha M; Rehman HU; Nawaz M; Wadood A; Imran S; Uddin I; Mosaddik A; Khan KM Bioorg Chem; 2018 Aug; 78():201-209. PubMed ID: 29597114 [TBL] [Abstract][Full Text] [Related]
23. In vitro α-Glucosidase Inhibition by Non-sugar based Triazoles of Dibenzoazepine, their Structure-Activity Relationship, and Molecular Docking. Khan MA; Javaid K; Wadood A; Jamal A; Batool F; Fazal-Ur-Rehman S; Basha FZ; Choudhary MI Med Chem; 2017; 13(7):698-704. PubMed ID: 28745232 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives. Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126 [TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors. Wang G; He D; Li X; Li J; Peng Z Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016 [TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors. Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031 [TBL] [Abstract][Full Text] [Related]
27. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors. Wang G; Peng Z; Wang J; Li J; Li X Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton. Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449 [TBL] [Abstract][Full Text] [Related]
29. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates. Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, In Vitro α-Glucosidase Inhibitory Activity and Molecular Docking Studies of Novel Benzothiazole-Triazole Derivatives. Gong Z; Peng Y; Qiu J; Cao A; Wang G; Peng Z Molecules; 2017 Sep; 22(9):. PubMed ID: 28914795 [TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies. Peytam F; Adib M; Shourgeshty R; Mohammadi-Khanaposhtani M; Jahani M; Imanparast S; Faramarzi MA; Mahdavi M; Moghadamnia AA; Rastegar H; Larijani B Mol Divers; 2020 Feb; 24(1):69-80. PubMed ID: 30825061 [TBL] [Abstract][Full Text] [Related]
33. Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives. Shafique K; Farrukh A; Mahmood Ali T; Qasim S; Jafri L; Abd-Rabboh HSM; Al-Anazy MM; Kalsoom S Molecules; 2023 Mar; 28(7):. PubMed ID: 37049866 [TBL] [Abstract][Full Text] [Related]
34. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study. Al-Salahi R; Ahmad R; Anouar E; Iwana Nor Azman NI; Marzouk M; Abuelizz HA Future Med Chem; 2018 Aug; 10(16):1889-1905. PubMed ID: 29882426 [TBL] [Abstract][Full Text] [Related]
35. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors. Wang G; Wang J; He D; Li X; Li J; Peng Z Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456 [TBL] [Abstract][Full Text] [Related]
36. Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of α-glucosidase inhibitors. Wang G; Peng Z; Gong Z; Li Y Bioorg Chem; 2018 Aug; 78():195-200. PubMed ID: 29587132 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as α-glucosidase inhibitors. Wang G; Chen M; Wang J; Peng Y; Li L; Xie Z; Deng B; Chen S; Li W Bioorg Med Chem Lett; 2017 Jul; 27(13):2957-2961. PubMed ID: 28506754 [TBL] [Abstract][Full Text] [Related]
38. Molecular docking studies and synthesis of novel bisbenzimidazole derivatives as inhibitors of α-glucosidase. Özil M; Emirik M; Beldüz A; Ülker S Bioorg Med Chem; 2016 Nov; 24(21):5103-5114. PubMed ID: 27576293 [TBL] [Abstract][Full Text] [Related]
39. Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones. Sun H; Li Y; Zhang X; Lei Y; Ding W; Zhao X; Wang H; Song X; Yao Q; Zhang Y; Ma Y; Wang R; Zhu T; Yu P Bioorg Med Chem Lett; 2015 Oct; 25(20):4567-71. PubMed ID: 26351039 [TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of novel pyridazine N-aryl acetamides: In-vitro evaluation of α-glucosidase inhibition, docking, and kinetic studies. Moghimi S; Toolabi M; Salarinejad S; Firoozpour L; Sadat Ebrahimi SE; Safari F; Mojtabavi S; Faramarzi MA; Foroumadi A Bioorg Chem; 2020 Sep; 102():104071. PubMed ID: 32688112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]